Drug firm eyes expansion
84465
An international pharmaceutical company is eyeing Lexington as its new center of operations for genetic therapies, promising hundreds of high-paying jobs and a $394 million investment over the next four years.
434278
Surgical software will help the company expand.
664968
Promising drug test results make this a company to watch.
685744
The Medicines Company reacquires its own drug.
751523
A new addition to an already successful drug promises good results for investors.
81672
The pharmaceutical giant is selling its pain relievers and other consumer products.
471781
The company is ready to handle competition from generics.
755377
With the water business dealt with, the company can refocus its energies on growing the business.
75091
The world's largest generics maker continues to post strong growth by bedeviling Big Pharma.
479126
Strong drug sales provide a dose of good medicine for this pharmaceutical company.
567272
The company teams up with AstraZeneca to bring its antibiotic to worldwide markets.
43938
Northern Irish drug maker Warner Chilcott says it has received an approach from a second party interested in bidding for the company, raising the prospect of a 1.5-billion-pound takeover battle.
640990
Now might be a great time to load up on cutting-edge drug makers.
174409
The company's lead drug will enter phase 1 trials, bringing potential good fortune to investors.
160226
The contract drug research company shares surged as the firm showed signs of new life.
562473
The drugmaker announces another great quarter of growth.
430908
This little drug maker has the potential for big profit, in both the U.S. and Europe.